# Effects of Sacrosidase and Placebo in Subjects With Fructan Intolerance

> **NCT05703009** · PHASE2 · COMPLETED · sponsor: **QOL Medical, LLC** · enrollment: 25 (actual)

## Conditions studied

- Fructan Intolerance

## Interventions

- **DRUG:** Sacrosidase Oral Solution
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05703009
- **Lead sponsor:** QOL Medical, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-05
- **Primary completion:** 2024-01-22
- **Final completion:** 2024-01-22
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2024-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05703009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05703009, "Effects of Sacrosidase and Placebo in Subjects With Fructan Intolerance". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05703009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*